Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
TMRC Logo
TMRC Growth Score
82
CB Rank
2908371
Heat Score
54
TMRC is a pharma company that researches, develops anti-cancer drugs and other cancer-related drug.
Acquired by
RaQualia Pharma Logo
RaQualia Pharma
Founded
obfuscation
Private Tokyo, Tokyo, Japan11-50 www.tmrc.co.jp
Biotechnology
Communities
Health Care
Medical
Pharmaceutical
Overview

TMRC
Growth Score
82
Heat Score
54

Growth Score82
-5 pts
in past quarter
Heat Score 54
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About TMRC

CB Rank
2908371
TMRC is a pharma company that researches, develops anti-cancer drugs and other cancer-related drug.
Acquired by
RaQualia Pharma Logo
RaQualia Pharma
Founded
obfuscation
Private Tokyo, Tokyo, Japan11-50 www.tmrc.co.jp
Biotechnology
Communities
Health Care
Medical
Pharmaceutical

Key People

Details

Legal Name TMRC Co., Ltd
Operating Status Active
Company Type For Profit
Phone Number +81 3 5215 2814
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Tamibarotene
Tamibarotene is a drug used to treat acute promyelocytic leukemia (APL), especially in patients resistant to all-trans retinoic acid (ATRA).

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

M&A Details

TMRC was acquired by RaQualia Pharma on
obfuscation
.
Transaction Name 
TMRC acquired by RaQualia Pharma Logo
TMRC acquired by RaQualia Pharma
Acquired by 
RaQualia Pharma Logo
RaQualia Pharma
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Active Website Tech Count

4TMRC is actively using 4 technologies for its website, according to BuiltWith. These include Euro, CommonCrawl Top 10m, and  Pound Sterling.

Total IP

5The intellectual property of TMRC includes 5 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is TMRC's headquarters? TMRC is located in Tokyo, Tokyo, Japan.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(85d1f87 1)
|